Related Experiment Video
Updated: Jun 22, 2026

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Medicare in interventional pain management: A critical analysis
1Pain Management Center of Paducah, Paducah, Kentucky 42003, USA. drm@apex.net
Pain Physician
|August 4, 2006
Summary
Interventional pain management faces significant changes due to the Deficit Reduction Act of 2005, impacting Medicare physician payments and utilization. Physicians must navigate evolving reimbursement, coding, and regulatory issues for 2006 and beyond.
Area of Science:
- Pain Medicine
- Health Policy
- Medical Economics
Background:
- The Deficit Reduction Act of 2005 significantly altered the Medicare payment system.
- Previous Medicare fee structures were insufficient to control rising physician service expenditures.
- The Sustained Growth Rate (SGR) system was implemented to manage spending increases.
Purpose of the Study:
- To analyze the impact of the Deficit Reduction Act of 2005 on interventional pain management.
- To examine the future economic and policy challenges for interventional pain physicians.
- To understand the evolution of Medicare physician payment reforms.
Main Methods:
- Analysis of the Deficit Reduction Act of 2005 provisions affecting physician payments.
- Review of Medicare payment system components, including Parts A, B, C, and D.
- Examination of the Sustained Growth Rate (SGR) formula and its components.
- Assessment of trends in interventional procedure utilization since 1998.
Main Results:
- The Deficit Reduction Act of 2005 introduced a 0% conversion factor update for physician services in 2006.
- Medicare spending per beneficiary grew significantly (11.6% annually) from 1980-1991, necessitating reforms.
- Interventional procedure utilization has increased substantially since 1998.
Conclusions:
- Interventional pain physicians face a complex landscape of reimbursement discrepancies, CPT coding challenges, and utilization concerns.
- The SGR system aims to control physician service spending through a formula based on fees, enrollment, GDP growth, and regulatory changes.
- Navigating these economic and policy shifts is crucial for interventional pain management in 2006 and beyond.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

